Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-07

Clinical Trial Update: Microplasmin Administered Via the Trellis-8 Infusion System for Treatment of Acute Iliofemoral DVT [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating microplasmin delivered via the Trellis-8 infusion system for acute iliofemoral deep vein thrombosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • microplasmin (microplasmin)

Snippet

Sponsor: ThromboGenics | Conditions: Deep Vein Thrombosis | Phase 2 | Status: TERMINATED